Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)

Author(s):
Groot, S. de; Janssen, L.G.M.; Charehbili, A.; Dijkgraaf, E.M.; Smit, V.T.H.B.M.; Kessels, L.W.; Bochove, A. van; Laarhoven, H.W.M. van; Kranenbarg, E.M.K.; Leeuwen-Stok, A.E. van; Velde, C.J.H. van de (0000-0003-0104-1800); Putter, H.; Nortier, J.W.R.; Hoeven, J.J.M. van der (0000-0003-1117-1959); Pijl, H. (0000-0002-3076-1551); Kroep, J.R.
Published
2015
Publication type
Article / Letter to editor
Breast cancerThyroid hormonesChemotherapyToxicitypCR
Date issued
2015-01-31
Language
English
Is part of
Breast Cancer Research and Treatment (2015), Vol. 149, no. 2, p. 461-466
hdl
1887/107865
doi
10.1007/s10549-014-3256-4